Literature DB >> 8376000

Comparative evaluation of digital radiography versus conventional radiography of fractured skulls.

H J Langen1, H M Klein, B Wein, A Stargardt, R W Günther.   

Abstract

OBJECTIVES: The authors assessed the relative efficacy of conventional and digital storage-phosphor radiographs for the detection of skull fractures.
METHODS: Fifty conventional film-screen radiographs (FSR) and 50 digital storage-phosphor radiographs (DR) with 66 fractures were compared. Five radiologists evaluated image quality and fracture detectability. The results were analyzed by receiver operating characteristic (ROC) curve analysis.
RESULTS: With a standard exposure, the ability to evaluate skull fractures was equally good with either technique (ROC area for DR, 0.8954; for FSR, 0.8870). Digital radiography was superior in evaluating nasal bone. For petrosal bone, the DR image simulates an underexposure. This disadvantage compared with FSR can be compensated by image postprocessing.
CONCLUSION: In evaluation of skull fractures, radiologists performance with DR is equivalent to FSR.

Entities:  

Mesh:

Year:  1993        PMID: 8376000     DOI: 10.1097/00004424-199308000-00005

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  3 in total

1.  Are digital images good enough? A comparative study of conventional film-screen vs digital radiographs on printed images of total hip replacement.

Authors:  K Eklund; K Jonsson; G Lindblom; B Lundin; J Sanfridsson; M Sloth; B Sivberg
Journal:  Eur Radiol       Date:  2003-11-14       Impact factor: 5.315

2.  Strict X-ray beam collimation for facial bones examination can increase lens exposure.

Authors:  R Powys; J Robinson; P L Kench; J Ryan; P C Brennan
Journal:  Br J Radiol       Date:  2012-02-28       Impact factor: 3.039

3.  Digital radiology in skeletal trauma: assessment of casualty officers' performance.

Authors:  J H Gillard; C Hubbard; R Das; H Sherriff
Journal:  J R Soc Med       Date:  1998-03       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.